FABP1 and COVID-19: In our previous multicenter study, we used urine L-FABP in COVID-19 to predict serious outcomes32 The area under the curve of L-FABP for predicting serious outcomes, including ventilator placement, was 96.3% (95% CI 92.6–98.8%), with a cutoff of 35.9 μg/gCre.